Putative protein markers in the sera of men with prostatic neoplasms

BJU International

Volumn 92, Issue 3, 2003, Pages 223-225

  Lehrer, S ^a,b   Roboz, J ^a   Ding, H ^a   Zhao, S ^a   Diamond, E J ^a   Holland, J F ^a   Stone, N N ^a   Droller, M J ^a   Stock, R G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Marker protein; Prognosis; Prostate cancer

Indexed keywords

BIOCHEMICAL MARKER; PLASMA PROTEIN;

ARTICLE; BLOOD ANALYSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN CHIEF ARRAY SURFACE ENHANCED LASER DESORPTION IONIZATION; RANK SUM TEST; STATISTICAL SIGNIFICANCE; VELOCITY;

HUMANS; MALE; NEOPLASM PROTEINS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042134515     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04341.x     Document Type: Article

References (7)

1. Oh WK, Hurwitz M, D'Amico AV, Richie JP, Kantoff PW. Neoplasms of the prostate. In Kufe DW, Pollock RE, Weichselbaum RR et al., eds, Holland-Frei Cancer Medicine, Chap. 111, 6th edn. Hamilton, Ontario, Canada: Decker Inc., 2003: 1707-40
2. Paweletz CP, Liotta LA, Petricoin EF. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 2001; 57 (Suppl. 4A): 160-3
3. Wang S, Diamond DL, Hass GM, Sokoloff R, Vessella RL. Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by protein chip array, surface-enhanced laser desorption/ionization (SELDI) technology. Int J Cancer 2001; 92: 871-6
4. Xiao Z, Adam BL, Cazares LH et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res 2001; 61: 6029-33
5. Petricoin E, F3 Ornstein DK, Paweletz CP et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576-8
6. Roboz J, Ma L, Sung M, Holland JF. Protein profiles in colon cancer by SELDI-TOF mass spectrometry. Proc AACR 2002; 43: 37
7. Dolios G, Roboz J, Wang R. Identification of colon cancer associating protein in plasma using MALDI-TOF mass spectrometry. Presented at the 51st ASMS Conference on Mass Spectrometry, 2003